| Code | 5574A | ||||||||||
| MA number | 44/0766/09-S | ||||||||||
| Product Form: | sol iru 4x0,75 ml/15 mg (striek.skl.napl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass pre-filled syringe | ||||||||||
| Route of admin.: | Subcutaneous, intramuscular and intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.11.2009 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Methotrexat Sandoz 20 mg_ml_01.2023.pdf
|
| PIL: |
PIL_Methotrexat Sandoz 20 mg_ml_01.2024.pdf
|
| Safety feature | Yes |
| Data update: | 25.01.2023 |
